FdaApplication

ANDA 040750

Back to search

Identifiers

Properties

PropertyValue
applicant_nameOXFORD PHARMACEUTICALS LLC
application_typeANDA
approval_date2006-08-29

Products (3)

ProductActive ingredientStrengthDosage form
SPIRONOLACTONESPIRONOLACTONE100MGTABLET;ORAL
SPIRONOLACTONESPIRONOLACTONE50MGTABLET;ORAL
SPIRONOLACTONESPIRONOLACTONE25MGTABLET;ORAL

3 products